Albrecht Stenzinger

Also affiliated with Heidelberg University, University Hospital Heidelberg, HeidelbergCement (Germany)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)”.

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Genetics in Medicine(2022)10.1016/j.gim.2022.01.001

N/A

0.829DataRank · unranked

250 citations

Malachi Griffith, Arpad Danos, Beth A. Pitel, Subha Madhavan, Xue‐Lu Liu +42 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100369

N/A

0.312DataRank · unranked

7 citations

Rastislav Horos, Paul Kittner, Mustafa Kahraman, Tobias Sikosek, Franziska Hinkfoth +9 more

In vivo variability of MRI radiomics features in prostate lesions assessed by a test-retest study with repositioning

Scientific Reports(2025)10.1038/s41598-025-09989-7

N/A

0.208DataRank · unranked

3 citations

Christian Jan Oliver Neelsen, Markus Wennmann, Thomas Hielscher, Balint Kovacs, Philip Alexander Glemser +7 more

The Added Value of Genome-Wide Copy Numbers to Objectively Resolve Clonality of Multiple Tumors With Pulmonary Involvement and Ambiguous or Inconclusive Mutational Diagnosis

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100921

N/A

0DataRank · unranked

0 citations

Bárbara Andrade Barbosa, Tim R. Mocking, Hendrik F. van Essen, Paul P. Eijk, Jacqueline Egthuijsen +11 more

174P Frequency and prognostic value of circulating tumor cells in cancer of unknown primary

Annals of Oncology(2023)10.1016/j.annonc.2023.09.2898

N/A

0DataRank · unranked

1 citations

Sabine Riethdorf, Tilmann Bochtler, Cornelia Coith, Bianca Kraft, Thomas Hielscher +4 more